Filimoniuk, A.; Blachnio-Zabielska, A.; Imierska, M.; Lebensztejn, D.M.; Daniluk, U.
Sphingolipid Analysis Indicate Lactosylceramide as a Potential Biomarker of Inflammatory Bowel Disease in Children. Biomolecules 2020, 10, 1083.
https://doi.org/10.3390/biom10071083
AMA Style
Filimoniuk A, Blachnio-Zabielska A, Imierska M, Lebensztejn DM, Daniluk U.
Sphingolipid Analysis Indicate Lactosylceramide as a Potential Biomarker of Inflammatory Bowel Disease in Children. Biomolecules. 2020; 10(7):1083.
https://doi.org/10.3390/biom10071083
Chicago/Turabian Style
Filimoniuk, Aleksandra, Agnieszka Blachnio-Zabielska, Monika Imierska, Dariusz Marek Lebensztejn, and Urszula Daniluk.
2020. "Sphingolipid Analysis Indicate Lactosylceramide as a Potential Biomarker of Inflammatory Bowel Disease in Children" Biomolecules 10, no. 7: 1083.
https://doi.org/10.3390/biom10071083
APA Style
Filimoniuk, A., Blachnio-Zabielska, A., Imierska, M., Lebensztejn, D. M., & Daniluk, U.
(2020). Sphingolipid Analysis Indicate Lactosylceramide as a Potential Biomarker of Inflammatory Bowel Disease in Children. Biomolecules, 10(7), 1083.
https://doi.org/10.3390/biom10071083